Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 278,633 | 264,566 | 244,317 | 259,602 | 250,401 |
| Cost of Goods | 21,647 | 20,734 | 20,392 | 21,803 | 18,857 |
| Gross Profit | 256,986 | 243,832 | 223,925 | 237,799 | 231,544 |
| Operating Expenses | 221,877 | 212,192 | 205,027 | 85,099 | 200,757 |
| Operating Income | 35,756 | 32,374 | 19,290 | 153,503 | 31,644 |
| Other Income | 8,839 | 7,837 | 8,489 | 7,582 | 7,162 |
| Pre-tax Income | 44,595 | 40,211 | 27,779 | 161,085 | 38,806 |
| Income Tax | -27,184 | 13,545 | 8,792 | 17,343 | 6,041 |
| Net Income Continuous | 71,779 | 26,666 | 18,987 | 143,742 | 32,765 |
| Net Income | $71,779 | $26,666 | $18,987 | $143,742 | $32,765 |
| EPS Basic Total Ops | 0.43 | 0.16 | 0.11 | 0.87 | 0.20 |
| EPS Basic Continuous Ops | 0.43 | 0.16 | 0.11 | 0.87 | 0.20 |
| EPS Diluted Total Ops | 0.42 | 0.16 | 0.11 | 0.86 | 0.20 |
| EPS Diluted Continuous Ops | 0.42 | 0.16 | 0.11 | 0.86 | 0.20 |
| EPS Diluted Before Non-Recurring Items | 0.26 | 0.16 | 0.11 | 0.17 | 0.20 |
| EBITDA(a) | $37,604 | $33,773 | $20,125 | $155,900 | $31,467 |